Source: European Medicines Agency (EU) Revision Year: 2019 Publisher: Akebia Europe Limited, c/o Matheson, 70 Sir John Rogersons Quay, Dublin 2, Ireland
Fexeric 1 g film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Peach-coloured, oval shaped, film-coated tablet, embossed with “KX52”. Tablets are 19 mm long, 7.2 mm thick and 10 mm wide. |
Each film-coated tablet contains 1 g of ferric citrate coordination complex (equivalent to 210 mg of ferric iron).
Excipients with known effect: Each film-coated tablet contains sunset yellow FCF (E110) (0.99 mg) and Allura Red AC (E129) (0.70 mg).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ferric citrate |
Ferric citrate is a phosphate binder and iron replacement product. It is used for the control of serum phosphorus levels and the treatment of iron deficiency anemia in adult patients with chronic kidney disease on dialysis. |
| List of Excipients |
|---|
|
Tablet core: Starch, pregelatinised Film-coating: Hypromellose |
HDPE bottles with child-resistant closure with desiccant.
Pack size: 200 film-coated tablets.
Akebia Europe Limited, c/o Matheson, 70 Sir John Rogerson’s Quay, Dublin 2, Ireland
EU/1/15/1039/001
Date of first authorisation: 23 September 2015
| Drug | Countries | |
|---|---|---|
| FEXERIC | Austria, Estonia, Ireland, Lithuania, Poland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
